Genome Sequencing Shows Clinical Promise in AML and ALL Genome Sequencing Shows Clinical Promise in AML and ALL

Whole genome sequencing could soon be used clinically to better characterise tumour profiles in leukaemia patients, potentially improving genomic stratification and therapy choices, say UK scientists.Medscape News UK
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news